Suryawanshi R, Chen I, Ma T, Syed A, Brazer N, Saldhi P, et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature. 2022;607:351-355 pubmed publisher

Suryawanshi R, Chen I, Ma T, Syed A, Brazer N, Saldhi P, et al. Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination. medRxiv. 2022;: pubmed publisher

Walter M, Chen I, Vallejo Gracia A, Kim I, Bielska O, Lam V, et al. SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. bioRxiv. 2022;: pubmed publisher

Syed A, Ciling A, Khalid M, Sreekumar B, Chen P, Kumar G, et al. Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles. medRxiv. 2022;: pubmed publisher

Filbin M, Mehta A, Schneider A, Kays K, Guess J, Gentili M, et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep Med. 2021;2:100287 pubmed publisher